University of Massachusetts Chan Medical School
Worcester, United States
Publications on this disease7
Research view
Switch to patient viewFrontotemporal dementia: who works on it
Groups that published on this disease or run trials on it, from public registries and publications. Researchers appear by name only once their profile is published.
Find fellow researchers
One card per institution. Pick a target or a country to narrow the list.
- All targets
- TDP-43 4
- C9orf72 0
- MAPT 2
- TREM2 0
- CSF1R 0
- SOD1 0
- NRF2 0
- AKT 0
- APOE 0
- CDK4/6 0
- GLP-1 0
- HMGB1 0
- LRRK2 0
- MAPK 0
- NLRP3 0
- SIRT1 0
- SNCA 0
- STING 0
- TP53 0
1 of 1+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.
Running research funding
Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-SE
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-DN
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-ERC
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-SE
Translational METabolomics for NEurodegenerative Diseases dIAgnosis and prognosis (METNEDIA)
The disease is named only in the funder's project summary, not in the title.
5 of 8 running projects, newest first. Listed amounts together: €17.7m.
Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.
Who stopped a trial, and why
Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.
Withdrawn
“This study is not a clinical trial.”Registry text, quoted unchanged. Source
Trials that share participant data
Trials whose registry record says individual participant data (IPD) will be shared.
No trial in this view states that it shares participant data.
Search by method
Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.
- Single-Cell Analysis 1
- Organoids 4
- Mendelian Randomization Analysis 10
- CRISPR-Cas Systems 1
- Gene Expression Profiling 4
- Whole Genome Sequencing 3
- Exome Sequencing 1
- Proteomics 17
- Metabolomics 1
- Mass Spectrometry 1
- Flow Cytometry 2
- Immunohistochemistry 1
- Positron-Emission Tomography 28
- Magnetic Resonance Imaging 74
- Machine Learning 18
- Deep Learning 9
- Cohort Studies 34
- Genome-Wide Association Study 13
Altered Membrane Protein Abundance in the Cerebral Cortex of the JNPL3 Mouse Model of Tauopathy.
Distinct proteomic CSF profiles in genetic frontotemporal lobar degeneration.
Proteome-wide Mendelian randomization identifies causal plasma proteins in frontotemporal dementia.
Plasma Proteomic Changes in GRN and C9orf72 Frontotemporal Dementia.
Dementia etiology classification using NULISA plasma biomarkers and machine learning.
Proteomic analysis in Alzheimer's disease and other dementias: a focus on sex-specific differences.
Paste an abstract
See which targets of this disease your abstract mentions, and go to the people working on them.
Matched in your browser only. The text is not sent, saved or logged.
Sources: ClinicalTrials.gov, EU CTR, OpenAlex, PubMed, NIH RePORTER, CORDIS. Machine-matched links are labelled.